Anti-™EM126A monoclonal antibody

Pre-made anti-™EM126A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ™EM126A/™EM126A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1968-Ab-1/ GM-Tg-hg-IP1968-Ab-2Anti-Human ™EM126A monoclonal antibodyHuman
GM-Tg-rg-IP1968-Ab-1/ GM-Tg-rg-IP1968-Ab-2Anti-Rat ™EM126A monoclonal antibodyRat
GM-Tg-mg-IP1968-Ab-1/ GM-Tg-mg-IP1968-Ab-2Anti-Mouse ™EM126A monoclonal antibodyMouse
GM-Tg-cynog-IP1968-Ab-1/ GM-Tg-cynog-IP1968-Ab-2Anti-Cynomolgus/ Rhesus macaque ™EM126A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1968-Ab-1/ GM-Tg-felg-IP1968-Ab-2Anti-Feline ™EM126A monoclonal antibodyFeline
GM-Tg-cang-IP1968-Ab-1/ GM-Tg-cang-IP1968-Ab-2Anti-Canine ™EM126A monoclonal antibodyCanine
GM-Tg-bovg-IP1968-Ab-1/ GM-Tg-bovg-IP1968-Ab-2Anti-Bovine ™EM126A monoclonal antibodyBovine
GM-Tg-equg-IP1968-Ab-1/ GM-Tg-equg-IP1968-Ab-2Anti-Equine ™EM126A monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1968-Ab-1/ GM-Tg-hg-IP1968-Ab-2; GM-Tg-rg-IP1968-Ab-1/ GM-Tg-rg-IP1968-Ab-2;
GM-Tg-mg-IP1968-Ab-1/ GM-Tg-mg-IP1968-Ab-2; GM-Tg-cynog-IP1968-Ab-1/ GM-Tg-cynog-IP1968-Ab-2;
GM-Tg-felg-IP1968-Ab-1/ GM-Tg-felg-IP1968-Ab-2; GM-Tg-cang-IP1968-Ab-1/ GM-Tg-cang-IP1968-Ab-2;
GM-Tg-bovg-IP1968-Ab-1/ GM-Tg-bovg-IP1968-Ab-2; GM-Tg-equg-IP1968-Ab-1/ GM-Tg-equg-IP1968-Ab-2
Products NameAnti-™EM126A monoclonal antibody
Formatmab
Target Name™EM126A
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-™EM126A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1968-Ag-1Recombinant multi-species T126A/ ™EM126A/ OPA7 protein


    Target information

    Target IDGM-IP1968
    Target Name™EM126A
    Gene ID84233,66271,293113,702831,608427,101097414,529762,100061387
    Gene Symbol and Synonyms1810020E01Rik,OPA7,RGD1305677,™EM126A
    Uniprot AccessionQ9H061,Q5HZA9,Q32L86
    Uniprot Entry NameT126A_HUMAN,T126A_RAT,T126A_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000171202
    Target ClassificationN/A

    The target: ™EM126A, gene name: ™EM126A, also named as OPA7. The protein encoded by this gene is a mitochondrial membrane protein of unknown function. Defects in this gene are a cause of optic atrophy type 7 (OPA7). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.